This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.
With earnings season just about down, our attention turns to economic data for s...
Tempus AI rose by as much as 15% on Friday after the health-care diagnostics com...
The court found that anti-abortion doctors who questioned the FDA’s easing of ac...
While lower borrowing costs would likely benefit the overall market, several nam...
Jim Cramer's daily rapid fire looks at stocks in the news outside the CNBC Inves...
A new round of Covid shots is coming. Meanwhile, the White House is partnering w...
Companies like The Vitamin Shoppe are leaning into protein and other supplements...
Abbott has FDA clearance for two new over-the-counter continuous glucose monitor...
Counterfeit diabetes test strips have been sold on Amazon and shipped to patient...
Donald Trump and President Biden are scheduled for their first presidential deba...
CityMD is backed by Walgreens Boots Alliance and operates over 100 walk-in urgen...
Drugmakers released cancer data at ASCO, with AstraZeneca taking center stage. A...
The rapid rise of weight loss drugs is generating a host of new product lines as...
Shares of Waystar fell in their trading debut on Friday in one of the first tech...
The rapid rise of weight loss drugs Wegovy and Mounjaro is generating a host of ...
Oscar Health CEO Mark Bertolini sees the small- and mid-size employer market as ...